Solid Biosciences Inc.
SLDB
$3.37
$0.072.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.60M | -32.73M | -25.07M | -24.30M | -20.34M |
| Total Depreciation and Amortization | 488.00K | 405.00K | 1.24M | 327.00K | 213.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.34M | 5.78M | 2.29M | 977.00K | 1.81M |
| Change in Net Operating Assets | 2.13M | 2.84M | 78.00K | -2.19M | -2.51M |
| Cash from Operations | -29.65M | -23.71M | -21.47M | -25.19M | -20.82M |
| Capital Expenditure | -204.00K | -15.00K | -286.00K | -149.00K | -90.00K |
| Sale of Property, Plant, and Equipment | 5.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.77M | -10.97M | -4.89M | -38.34M | 45.39M |
| Cash from Investing | 38.57M | -10.99M | -5.18M | -38.49M | 45.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -128.00K | -120.00K | -225.00K | -- | -- |
| Issuance of Common Stock | 7.07M | 3.38M | 5.51M | 112.07M | 505.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -286.00K | -4.83M | -- |
| Cash from Financing | 6.94M | 3.26M | 5.00M | 107.24M | 505.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.86M | -31.44M | -21.64M | 43.56M | 24.98M |